ArticleAmerican journal of respiratory and critical care medicine2023
A Call for the United States to Accelerate the Implementation of Reliever Combination Inhaled Corticosteroid-Formoterol Inhalers in Asthma.
Article in American journal of respiratory and critical care medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 21 citations in OpenAlex.
- As-needed inhaled corticosteroids in asthma: from evidence to implementation.Current opinion in pulmonary medicine · 2026Review
- Costs of Single Maintenance and Reliever Therapy vs Traditional Therapy for Asthma.JAMA network open · 2026Article
- Pediatric Asthma in a Universally Insured Military Population.JAMA network open · 2026Article
- Development of a patient-centered asthma action plan for single maintenance and reliever therapy (MART).The journal of allergy and clinical immunology. Global · 2026Article
- Detecting heart failure in severe asthma patients using speckle tracking echocardiography.Critical care (London, England) · 2025Article
- A Strategy to Reduce Out-of-User-Life Utilization and Waste of Expired Budesonide-Formoterol Pressurized Metered-Dose Inhalers in Mild Asthma.Annals of the American Thoracic Society · 2025Article
- Call for the alignment of Medicare Part D formularies with clinical treatment guidelines for asthma.Journal of managed care & specialty pharmacy · 2025Article
- The Wiser Strategy of Using Beta-Agonists in Asthma: Mechanisms and Rationales.Allergy, asthma & immunology research · 2024Review
- The Role of ICS-Containing Rescue Therapy Versus SABA Alone in Asthma Management Today.The journal of allergy and clinical immunology. In practice · 2024Review
- Tracking the Trends in the Adoption of Reliever-Only ICS-Formoterol Therapy and SMART.The journal of allergy and clinical immunology. In practice · 2023Article
- Beginning to Address an Implementation Gap in Asthma: Clinicians' Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United States.The journal of allergy and clinical immunology. In practice · 2023Article
- Over-the-counter Dispensing: Widening Access to Inhaled Corticosteroid/Formoterol Reliever Therapy.American journal of respiratory and critical care medicine · 2023Article
Corrections and comments
- Commented on by
Authors and funding
15 authors at 11 institutions in 3 countries.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.